标题
Antithrombotic Agents and Cancer
作者
关键词
-
出版物
Cancers
Volume 10, Issue 8, Pages 253
出版商
MDPI AG
发表日期
2018-08-01
DOI
10.3390/cancers10080253
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents
- (2018) Xiaohong Ruby Xu et al. BLOOD
- Platelets and extracellular vesicles in cancer: diagnostic and therapeutic implications
- (2018) Melania Dovizio et al. CANCER AND METASTASIS REVIEWS
- The Platelet Lifeline to Cancer: Challenges and Opportunities
- (2018) Monika Haemmerle et al. CANCER CELL
- Ticagrelor inhibits platelet–tumor cell interactions and metastasis in human and murine breast cancer
- (2018) Alison J. Gareau et al. CLINICAL & EXPERIMENTAL METASTASIS
- P2Y12 Receptors in Tumorigenesis and Metastasis
- (2018) Patrizia Ballerini et al. Frontiers in Pharmacology
- Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer
- (2017) Alice Chanakira et al. GYNECOLOGIC ONCOLOGY
- Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats
- (2017) Juan Niu et al. Journal of Neuroinflammation
- Platelet RNA as a circulating biomarker trove for cancer diagnostics
- (2017) M. G. Best et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Curbing tumorigenesis and malignant progression through the pharmacological control of the wound healing process
- (2017) Melania Dovizio et al. VASCULAR PHARMACOLOGY
- Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway
- (2017) Weilong Zhong et al. Oncotarget
- Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition
- (2017) Meiling Tang et al. Oncotarget
- Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging
- (2017) May Lin Yap et al. Theranostics
- Purinergic Signalling: Therapeutic Developments
- (2017) Geoffrey Burnstock Frontiers in Pharmacology
- Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2016) Kirsten Bibbins-Domingo et al. ANNALS OF INTERNAL MEDICINE
- The role of platelets in the tumor microenvironment: From solid tumors to leukemia
- (2016) MengJie Yan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond
- (2016) Xiaohong Ruby Xu et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Extracellular matrix proteins in the regulation of thrombus formation
- (2016) Yiming Wang et al. CURRENT OPINION IN HEMATOLOGY
- Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis
- (2016) Rafail Angelos Kotronias et al. DRUG SAFETY
- Aspirin and Cancer
- (2016) Paola Patrignani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
- (2016) J. Park et al. Science Translational Medicine
- Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells
- (2016) Paloma Guillem-Llobat et al. Oncotarget
- Cyclooxygenase inhibitors: From pharmacology to clinical read-outs
- (2015) Paola Patrignani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
- (2015) Myron G. Best et al. CANCER CELL
- Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen
- (2015) G. N. Adams et al. CANCER RESEARCH
- αIIbβ3-integrin Ligands: Abciximab and Eptifibatide as Proapoptotic Factors in MCF-7 Human Breast Cancer Cells
- (2015) Joanna Kononczuk et al. CURRENT DRUG TARGETS
- New Insights into the Mechanism of Action of Aspirin in the Prevention of Colorectal Neoplasia
- (2015) Luigia Francesco et al. CURRENT PHARMACEUTICAL DESIGN
- Review of vorapaxar for the prevention of atherothrombotic events
- (2015) Amy Wang EXPERT OPINION ON PHARMACOTHERAPY
- The platelet P2 receptors in inflammation
- (2015) M. Cattaneo Hamostaseologie
- The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin
- (2015) Carlo Patrono JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments
- (2015) Jessica L Mega et al. LANCET
- Microparticles in cancer: A review of recent developments and the potential for clinical application
- (2015) Joyce Gong et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response
- (2015) Valdirene S. Muniz et al. PLoS One
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Purinergic signalling and immune cells
- (2014) Geoffrey Burnstock et al. Purinergic Signalling
- Role of Platelets in Inflammation and Cancer: Novel Therapeutic Strategies
- (2013) Melania Dovizio et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response
- (2013) E. M. Battinelli et al. BLOOD
- Roles for GP IIb/IIIa and αvβ3 integrins in MDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction
- (2013) Fenglong Zhao et al. CANCER LETTERS
- Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway
- (2013) A. Radziwon-Balicka et al. CARCINOGENESIS
- Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence
- (2013) Peggy Tilly et al. CARDIOVASCULAR RESEARCH
- Thrombin induces epithelial-mesenchymal transition via PAR-1, PKC, and ERK1/2 pathways in A549 cells
- (2013) Jeong Sup Song et al. EXPERIMENTAL LUNG RESEARCH
- P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer
- (2013) Sasmit Sarangi et al. MEDICAL ONCOLOGY
- Platelet P2Y12 Is Involved in Murine Pulmonary Metastasis
- (2013) Yanhua Wang et al. PLoS One
- Purinergic signalling and cancer
- (2013) Geoffrey Burnstock et al. Purinergic Signalling
- Novel antiplatelet drugs in clinical development
- (2013) Martin Ungerer et al. THROMBOSIS AND HAEMOSTASIS
- Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis
- (2013) Yan Hou et al. THROMBOSIS AND HAEMOSTASIS
- Neutrophil extracellular traps
- (2013) Mélanie Demers et al. OncoImmunology
- Platelets signal and tumors take off
- (2012) A. K. Rao et al. BLOOD
- A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment
- (2012) W. Zhang et al. BLOOD
- Primary and Secondary Prevention of Cardiovascular Disease
- (2012) Per Olav Vandvik et al. CHEST
- Inhibition of Protease-activated Receptor 1 Ameliorates Intestinal Radiation Mucositis in a Preclinical Rat Model
- (2012) Junru Wang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- The role of aspirin in cancer prevention
- (2012) Michael J. Thun et al. Nature Reviews Clinical Oncology
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multifaceted roles of PGE2 in inflammation and cancer
- (2012) Masako Nakanishi et al. Seminars in Immunopathology
- Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives
- (2012) Kallirroi I Kalantzi et al. Expert Review of Clinical Pharmacology
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
- (2011) T. Placke et al. CANCER RESEARCH
- Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans
- (2011) Martin Ungerer et al. CIRCULATION
- Pharmacokinetic basis of the antiplatelet action of prasugrel
- (2011) Karsten Schrör et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 Integrin Mediates Interaction of Melanoma Cells with Platelets
- (2011) Anke S. Lonsdorf et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-3 Facilitates Cell Motility in Gastric Cancer by Up-Regulating Protease-Activated Receptor-1(PAR-1) and Matrix Metalloproteinase-1(MMP-1)
- (2011) Seok-Jun Kim et al. PLoS One
- Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells
- (2011) Karl Egan et al. PLoS One
- Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook
- (2010) Victor Serebruany et al. AMERICAN JOURNAL OF THERAPEUTICS
- Deadly allies: the fatal interplay between platelets and metastasizing cancer cells
- (2010) L. Erpenbeck et al. BLOOD
- Anti-platelet therapy: glycoprotein IIb-IIIa antagonists
- (2010) David J. Schneider BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- New P2Y 12 Inhibitors
- (2010) Marco Cattaneo CIRCULATION
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Cancer and thrombosis: implications of published guidelines for clinical practice
- (2009) A. A. Khorana ANNALS OF ONCOLOGY
- Platelet-Derived Transforming Growth Factor- Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
- (2009) H.-G. Kopp et al. CANCER RESEARCH
- Platelet receptors and signaling in the dynamics of thrombus formation
- (2009) J. Rivera et al. HAEMATOLOGICA
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of Platelet GPIbα and Promotion of Melanoma Metastasis
- (2009) Luise Erpenbeck et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models
- (2009) S. JAIN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The role of COX-2 in intestinal inflammation and colorectal cancer
- (2009) D Wang et al. ONCOGENE
- Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
- (2009) Lars Petersen et al. THROMBOSIS AND HAEMOSTASIS
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons
- (2008) Alexandre Fontayne et al. THROMBOSIS AND HAEMOSTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started